Publications

Read the peer-reviewed papers providing the body of evidence to validate the new category of mental health care we’re establishing.

SHOWING 6 OF 11

14 Aug 2024Discovery
British Journal of Pharmacology
Evidence that 5-HT2A receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non-psychedelic drugs.
View publication
16 Jul 2026Discovery
Journal of Psychopharmacology
Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorder
View publication
10 Jan 2024Discovery
Science Translational Medicine
Rapid-acting antidepressant drugs modulate affective bias in rats.
View publication
01 Aug 2026Treatment-resistant depression
Journal of Affective Disorders
The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis.
View publication
03 Mar 2025Treatment-resistant depression
The Journal of Clinical Psychiatry
Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.
View publication
01 Mar 2025Treatment-resistant depression
Journal of Affective Disorders
The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.
View publication

See our clinical trials

We encourage you to visit clinicaltrials.gov to learn more about our clinical trials.